The effects of two different ganoderma species (Lingzhi) on gene expression in human monocytic THP-1 cells

Nutrition and Cancer

Volumn 62, Issue 5, 2010, Pages 648-658

  Cheng, Chun Huai ^a   Leung, Albert Y ^b   Chen, Chin Fu ^a  

^a CLEMSON UNIVERSITY   (United States)

^b Phyto Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CELL PROTEIN; GANODERMA LUCIDUM EXTRACT; GANODERMA SINENSE EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT; UNCLASSIFIED DRUG; CYP1B1 PROTEIN, HUMAN; CYTOCHROME P450; CYTOCHROME P450 1B1; GANODERMA LUCIDUM; HERBACEOUS AGENT; UNSPECIFIC MONOOXYGENASE;

ARTICLE; CELL ACTIVITY; CELL GROWTH; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MACROMOLECULE; MICROARRAY ANALYSIS; MONOCYTE; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; CELL LINE; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

BASIDIOMYCOTA; GANODERMA; GANODERMA LUCIDUM; GANODERMA SINENSE;

ARYL HYDROCARBON HYDROXYLASES; CELL LINE; CYTOCHROME P-450 CYP1B1; CYTOCHROME P-450 ENZYME SYSTEM; DRUGS, CHINESE HERBAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MONOCYTES; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 77953984078     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605516     Document Type: Article

References (30)

1. Wasser SP: Reishi or Ling Zhi (Ganodermalucidum). New York: Informa Healthcare, 2005.
2. Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China 2005 (English ed.). Beijing, China: Chemical Industry Press, 2005.
3. Huie CW and Di X: Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components. J Chromatogr B Analyt Technol Biomed Life Sci 812, 241-257, 2004.
4. Lakshmi B, Ajith TA, Sheena N, Gunapalan N, and Janardhanan KK: Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganodermalucidum occurring in South India. Teratog Carcinog Mutagen 23 (1 Suppl.), 85-97, 2003.
5. Lin ZB and Zhang HN: Anti-tumor and immunoregulatory activities of Ganodermalucidum and its possible mechanisms. Acta Pharmacol Sin 25, 1387-1395, 2004.
6. Yuen JW and Gohel MD: Anticancer effects of Ganodermalucidum: a review of scientific evidence. Nutr Cancer 53, 11-17, 2005.
7. Paterson RR: Ganoderma-a therapeutic fungal biofactory. Phytochemistry 67, 1985-2001, 2006.
8. Jiang J, Slivova V, Harvey K, Valachovicova T, and Sliva D: Ganodermalucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer 49, 209-216, 2004.
9. M̈uller CI, Kumagai T, O'Kelly J, Seeram NP, Heber D, et al.: Ganodermalucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res 30, 841-848, 2006.
10. GillSKandRieder MJ:Toxicity of a traditionalChinese medicine, Ganodermalucidum, in children with cancer. Can J Clin Pharmacol 15, e275-e285, 2008.
11. Chen CF and Leung AY: Gene response of human monocytic cells for the detection of antimigraine activity of feverfew extracts. Can J PhysiolPharmacol 85, 1108-1115, 2007.
12. Chen CF and Cheng CH: Regulation of cellular metabolism and cytokines by the medicinal herb feverfew in the human monocytic THP-1 Cells. Evid Based Complement Alternat Med 61, 91-98, 2009.
13. Abbas AK and Lichtman AH: Cellular and Molecular Immunology. Philadelphia: W. B. Saunders, 2003.
14. Roitt IM and Delves PJ: Roitt's Essential Immunology. Oxford, England Blackwell Science, Inc., 2001.
15. Gilroy DW, Lawrence T, Perretti M, and Rossi AG: Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3, 401-416, 2004.
16. Churchill GA: Fundamentals of experimental design for cDNAmicroarrays. Nat Genet 32(Suppl.), 490-495, 2002.
17. Smyth GK, Yang YH, and Speed T: Statistical issues in cDNA microarray data analysis. Methods Mol Biol 224, 111-136, 2003.
18. Tusher VG, Tibshirani R, and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98, 5116-5121, 2001.
19. Consortium GO: The Gene Ontology (GO) project in 2006. Nucleic Acids Res 34, D322-326, 2006.
20. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al.: Gene ontology: tool for the unification of biology: the Gene Ontology Consortium. Nat Genet 25, 25-29, 2000.
21. Al-Shahrour F, Diaz-Uriarte R, and Dopazo J: FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 20, 578-580, 2004.
22. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, et al.: A physical and functional map of the human TNF-alpha/NFkappa B signal transduction pathway. Nat Cell Biol 6, 97-105, 2004.
23. Jiang J, Slivova V, and Sliva D: Ganodermalucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Int J Oncol 29, 695-703, 2006.
24. Kuo MC, Weng CY, Ha CL, and Wu MJ: Ganodermalucidum mycelia enhance innate immunity by activating NF-kappaB. J Ethnopharmacol 103, 217-222, 2006.
25. Fujita R, Liu J, Shimizu K, Konishi F, Noda K, et al.: Anti-androgenic activities of Ganodermalucidum. J Ethnopharmacol 102, 107-112, 2005.
26. Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, et al.: Ganodermalucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett 216, 9-20, 2004.
27. Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, et al.: Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 11, 5793-5801, 2005.
28. Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, et al.: The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 86, 774-778, 2002.
29. Doostdar H, BurkeMD, and Mayer RT: Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 144, 31-38, 2000.
30. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al.: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848-853. 2007.